Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?
- PMID: 29537976
- PMCID: PMC5998848
- DOI: 10.14744/AnatolJCardiol.2018.57804
Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?
Comment in
-
Author`s Reply.Anatol J Cardiol. 2018 Apr;19(4):292. Anatol J Cardiol. 2018. PMID: 29615546 Free PMC article. No abstract available.
Comment on
-
Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation.Anatol J Cardiol. 2018 Jan;19(1):67-71. doi: 10.14744/AnatolJCardiol.2017.8256. Anatol J Cardiol. 2018. PMID: 29339702 Free PMC article. Review.
References
-
- Bhatt DL, Hulot JS, Moliterno DJ, Harrington RA. Antiplatelet and anticoagulation therapy for acute coronary syndromes. Circ Res. 2014;114:1929–43. - PubMed
-
- Bhatt DL. Intensifying platelet inhibition--navigating between Scylla and Charybdis. N Engl J Med. 2007;357:2078–81. - PubMed
-
- Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med. 2016;375:2423–34. - PubMed
-
- Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, et al. RE-DUAL PCI Steering Committee and Investigators. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2017;377:1513–24. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
